300 related articles for article (PubMed ID: 7788881)
1. Endothelial cell interactions with synthetic peptides from the carboxyl-terminal heparin-binding domains of fibronectin.
Huebsch JC; McCarthy JB; Diglio CA; Mooradian DL
Circ Res; 1995 Jul; 77(1):43-53. PubMed ID: 7788881
[TBL] [Abstract][Full Text] [Related]
2. Characterization of FN-C/H-V, a novel synthetic peptide from fibronectin that promotes rabbit corneal epithelial cell adhesion, spreading, and motility.
Mooradian DL; McCarthy JB; Skubitz AP; Cameron JD; Furcht LT
Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):153-64. PubMed ID: 8425821
[TBL] [Abstract][Full Text] [Related]
3. Photoreactive analog of peptide FN-C/H-V from the carboxy-terminal heparin-binding domains of fibronectin supports endothelial cell adhesion and spreading on biomaterial surfaces.
Huebsch JB; Fields GB; Triebes TG; Mooradian DL
J Biomed Mater Res; 1996 Aug; 31(4):555-67. PubMed ID: 8836853
[TBL] [Abstract][Full Text] [Related]
4. Rabbit corneal epithelial cells adhere to two distinct heparin-binding synthetic peptides derived from fibronectin.
Mooradian DL; McCarthy JB; Cameron JD; Skubitz AP; Furcht LT
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3034-40. PubMed ID: 1399408
[TBL] [Abstract][Full Text] [Related]
5. Role of the heparin-binding domain of chimeric peptides derived from fibronectin in cell spreading and motility.
Yoneda J; Saiki I; Igarashi Y; Kobayashi H; Fujii H; Ishizaki Y; Kimizuka F; Kato I; Azuma I
Exp Cell Res; 1995 Mar; 217(1):169-79. PubMed ID: 7867715
[TBL] [Abstract][Full Text] [Related]
6. Human keratinocytes adhere to and spread on synthetic peptide FN-C/H-V derived from fibronectin.
Wilke MS; Vespa J; Skubitz AP; Furcht LT; McCarthy JB
J Invest Dermatol; 1993 Jul; 101(1):43-8. PubMed ID: 8331295
[TBL] [Abstract][Full Text] [Related]
7. Human keratinocytes adhere to two distinct heparin-binding synthetic peptides derived from fibronectin.
Wilke MS; Skubitz AP; Furcht LT; McCarthy JB
J Invest Dermatol; 1991 Sep; 97(3):573-9. PubMed ID: 1875056
[TBL] [Abstract][Full Text] [Related]
8. A synthetic peptide, FN-C/H-V, from the C-terminal heparin-binding domain of fibronectin promotes adhesion of PMA stimulated U937 cells.
Kato K; Mohri H; Tamura T; Okubo T
Biochem Biophys Res Commun; 1997 Oct; 239(1):205-11. PubMed ID: 9345296
[TBL] [Abstract][Full Text] [Related]
9. A cell-surface heparan sulfate proteoglycan mediates neural cell adhesion and spreading on a defined sequence from the C-terminal cell and heparin binding domain of fibronectin, FN-C/H II.
Haugen PK; Letourneau PC; Drake SL; Furcht LT; McCarthy JB
J Neurosci; 1992 Jul; 12(7):2597-608. PubMed ID: 1613550
[TBL] [Abstract][Full Text] [Related]
10. Recognition of the A chain carboxy-terminal heparin binding region of fibronectin involves multiple sites: two contiguous sequences act independently to promote neural cell adhesion.
Haugen PK; McCarthy JB; Skubitz AP; Furcht LT; Letourneau PC
J Cell Biol; 1990 Dec; 111(6 Pt 1):2733-45. PubMed ID: 2277084
[TBL] [Abstract][Full Text] [Related]
11. Cell surface phosphatidylinositol-anchored heparan sulfate proteoglycan initiates mouse melanoma cell adhesion to a fibronectin-derived, heparin-binding synthetic peptide.
Drake SL; Klein DJ; Mickelson DJ; Oegema TR; Furcht LT; McCarthy JB
J Cell Biol; 1992 Jun; 117(6):1331-41. PubMed ID: 1607392
[TBL] [Abstract][Full Text] [Related]
12. Coordinate role for cell surface chondroitin sulfate proteoglycan and alpha 4 beta 1 integrin in mediating melanoma cell adhesion to fibronectin.
Iida J; Skubitz AP; Furcht LT; Wayner EA; McCarthy JB
J Cell Biol; 1992 Jul; 118(2):431-44. PubMed ID: 1629241
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin.
Verfaillie CM; McCarthy JB; McGlave PB
J Exp Med; 1991 Sep; 174(3):693-703. PubMed ID: 1875168
[TBL] [Abstract][Full Text] [Related]
14. RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities.
McCarthy JB; Skubitz AP; Qi Z; Yi XY; Mickelson DJ; Klein DJ; Furcht LT
J Cell Biol; 1990 Mar; 110(3):777-87. PubMed ID: 2307707
[TBL] [Abstract][Full Text] [Related]
15. Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor.
Verfaillie CM; Benis A; Iida J; McGlave PB; McCarthy JB
Blood; 1994 Sep; 84(6):1802-11. PubMed ID: 7521691
[TBL] [Abstract][Full Text] [Related]
16. Interaction of heparin with a synthetic pentadecapeptide from the C-terminal heparin-binding domain of fibronectin.
Hari SP; McAllister H; Chuang WL; Christ MD; Rabenstein DL
Biochemistry; 2000 Apr; 39(13):3763-73. PubMed ID: 10736176
[TBL] [Abstract][Full Text] [Related]
17. C-terminal heparin-binding domain of fibronectin regulates integrin-mediated cell spreading but not the activation of mitogen-activated protein kinase.
Kim J; Han I; Kim Y; Kim S; Oh ES
Biochem J; 2001 Nov; 360(Pt 1):239-45. PubMed ID: 11696013
[TBL] [Abstract][Full Text] [Related]
18. Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism.
Wijelath ES; Rahman S; Namekata M; Murray J; Nishimura T; Mostafavi-Pour Z; Patel Y; Suda Y; Humphries MJ; Sobel M
Circ Res; 2006 Oct; 99(8):853-60. PubMed ID: 17008606
[TBL] [Abstract][Full Text] [Related]
19. Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase.
Zagzag D; Shiff B; Jallo GI; Greco MA; Blanco C; Cohen H; Hukin J; Allen JC; Friedlander DR
Cancer Res; 2002 May; 62(9):2660-8. PubMed ID: 11980665
[TBL] [Abstract][Full Text] [Related]
20. A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation.
Woods A; McCarthy JB; Furcht LT; Couchman JR
Mol Biol Cell; 1993 Jun; 4(6):605-13. PubMed ID: 8374170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
